| Company Name | Exchange | Ticker | Last Price | Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Sandstorm Gold Ltd | TSX | SSL | 6.85 | 11 | Upgrade to hold from reduce | Daniel Earle | TD Securities | 6.50 | -5.1% |
| Capstone Mining Corp | TSX | CS | 2.52 | 21 | Upgrade to outperform from market perform | Aleksandra Bukacheva | BMO Capital Markets | 3.50 | 38.9% |
| Endeavour Silver Corp | TSX | EDR | 5.95 | 11 | Upgrade to buy from hold | Ash Guglani | Salman Partners | 6.50 | 9.2% |
| Ur-Energy Inc | TSX | URE | 1.94 | 7 | Initiate with buy | Christopher Chang | Laurentian Bank Securities | 2.60 | 34.0% |
| Newalta Corp | TSX | NAL | 19.00 | 10 | Downgrade to sector perform from sector outperform | Vladislav C Vlad | Scotia Capital | 20.00 | 5.3% |
TD Securities upgraded Sandstorm Gold Ltd (TSX: SSL), a gold streaming company engaged in providing finance to gold mining companies, to hold from reduce raising its price target to C$6.50 from C$4.50, indicating a downside of 5.1% from current levels. SSL recently reported that it achieved record fourth quarter gold sales of 10,523 ounces and 36,146 ounces for full year 2013. The company recorded revenues of $15.8 million and $59.8 million for fourth quarter and full year 2013 respectively.
Capstone Mining Corp (TSX: CS), a Canadian mining company engaged in the production and development of and the exploration for base and precious metals, was upgraded to outperform from market perform at BMO Capital Markets with a price target of C$3.50, indicating an upside of 38.9% from current levels.
Salman Partners upgraded Endeavour Silver Corp (TSX: EDR), engaged in the evaluation, acquisition, exploration, development and exploitation of silver mining properties, to buy from hold with a price target of C$6.50, indicating an upside of 9.2% from current levels. Recently, EDR reported that its silver production jumped 49% to 3 million ounces during the fourth quarter of 2013 .
Laurentian Bank Securities initiated coverage on Ur-Energy Inc (TSX: URE), an exploration-stage junior mining company engaged in the identification, acquisition, evaluation, exploration and development of uranium mineral properties, with a buy rating assigning a 12-month price target of C$2.60, indicating an upside of 34% from current levels.
Scotia Capital downgraded Newalta Corp (TSX: NAL), engaged in recycling and recovering saleable products from industrial wastes through a network of facilities, to sector perform from sector outperform with a price target of C$20.00, indicating an upside of 5.3% from current levels.
| Company Name | Exchange | Ticker | Last Price |
Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Infinera Corp | NASDAQ | INFN | 9.71 | 9 | Upgrade to buy/attractive from neutral/neutral | Simona Jankowski | Goldman Sachs | 11.50 | 18.4% |
| PharMerica Corp | NYSE | PMC | 26.49 | 8 | Upgrade to outperform from neutral | Glen Santangelo | Credit Suisse | 30.00 | 13.3% |
| AngioDynamics Inc | NASDAQ | ANGO | 16.76 | 5 | Upgrade to outperform from market perform | Jayson Bedford | Raymond James | 19.00 | 13.4% |
| Chimerix Inc | NASDAQ | CMRX | 24.58 | 7 | Initiate with buy | Brian Klein | Stifel | 34.00 | 38.3% |
| EPL Oil & Gas Inc | NYSE | EPL | 37.50 | 14 | Downgrade to market perform from outperform | Dan McSpirit | BMO Capital Markets | 39.00 | 4.0% |
Goldman Sachs upgraded Infinera Corp (NASDAQ: INFN), a provider of optical networking equipment, software and services, to buy/attractive from neutral/neutral with a price target of $11.50, indicating an upside of 18.4% from current levels. The rating firm believes that the company has a strong potential to bounce back with customer upgrades and market share gains in 100G long haul, which is forecast to grow at nearly a 40% CAGR through 2015.
PharMerica Corp (NYSE: PMC), an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals, was upgraded to outperform from neutral at Credit Suisse increasing its price target to $30.00 from $19.00, indicating an upside of 13.3% from current levels. The rating firm notes that the stock is well positioned trading at just 7.0x 2015 EBITDA estimate and with improving fundamentals & attractive capital deployment.
Raymond James upgraded AngioDynamics Inc (NASDAQ: ANGO), engaged in designing, manufacturing and selling a range of medical, surgical and diagnostic devices, to outperform from market perform with a price target of $19.00, indicating an upside of 13.4% from current levels. Recently, ANGO reported that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for its AngioVac cannula for venous drainage during extracorporeal bypass for up to six hours to include removal of fresh, soft thrombi or emboli.
Stifel initiated coverage on Chimerix Inc (NASDAQ: CMRX), a biopharmaceutical company committed to the discovery, development and commercialization of novel, oral antiviral therapeutics, with a buy rating assigning a 12-month price target of $34.00, indicating an upside of 38.3% from current levels.
BMO Capital Markets downgraded EPL Oil & Gas Inc (NYSE: EPL), an independent oil and natural gas exploration and production company, to market perform from outperform with a price target of $39.00, indicating an upside of 4% from current levels.
